Ladenburg Thalmann Financial Services’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-1,123
| Closed | -$202K | – | 5265 |
|
|
2017
Q3 | $202K | Sell |
1,123
-1,963
| -64% | -$353K | ﹤0.01% | 2102 |
|
|
2017
Q2 | $320K | Buy |
3,086
+627
| +25% | +$65K | ﹤0.01% | 1698 |
|
|
2017
Q1 | $193K | Buy |
2,459
+975
| +66% | +$76.5K | ﹤0.01% | 1940 |
|
|
2016
Q4 | $66K | Buy |
1,484
+284
| +24% | +$12.6K | ﹤0.01% | 2649 |
|
|
2016
Q3 | $67K | Buy |
1,200
+100
| +9% | +$5.58K | ﹤0.01% | 2564 |
|
|
2016
Q2 | $55K | Buy |
1,100
+200
| +22% | +$10K | ﹤0.01% | 2607 |
|
|
2016
Q1 | $41K | Buy |
900
+100
| +13% | +$4.56K | ﹤0.01% | 2749 |
|
|
2015
Q4 | $49K | Buy |
800
+125
| +19% | +$7.66K | ﹤0.01% | 2578 |
|
|
2015
Q3 | $38K | Buy |
675
+575
| +575% | +$32.4K | ﹤0.01% | 2664 |
|
|
2015
Q2 | $6K | Sell |
100
-147
| -60% | -$8.82K | ﹤0.01% | 4009 |
|
|
2015
Q1 | $14K | Buy |
+247
| New | +$14K | ﹤0.01% | 3434 |
|